Preclinical News and Research

RSS
Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice

Next-generation COVID-19 vaccine provides robust immunity against SARS-CoV-2 in mice

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Redhill Biopharma announces completion of Phase 2/3 COVID-19 study of oral opaganib

Chemical modification in RNA molecules may offer protection against liver disease

Chemical modification in RNA molecules may offer protection against liver disease

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

Researchers use appendiceal cancer organoids to study personalized immunotherapy response

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

New compounds can provide a breakthrough in the treatment of neurodegenerative pathologies

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

Evaluation of a synthetic DNA SARS-CoV-2 vaccine INO-4800 using a nonhuman primate model

'Super glue' from snake venom can stop life-threatening bleeding in seconds

'Super glue' from snake venom can stop life-threatening bleeding in seconds

COVID-19 vaccine candidate that can be produced in yeast proves effective in macaques

COVID-19 vaccine candidate that can be produced in yeast proves effective in macaques

Autophagy disruption may be at the root of early cognitive changes in Huntington’s disease

Autophagy disruption may be at the root of early cognitive changes in Huntington’s disease

Heart problems in kids with MIS-C resolve rapidly, study shows

Heart problems in kids with MIS-C resolve rapidly, study shows

Potential compounds targeting SARS-COV-2 main protease (in vivo)

Potential compounds targeting SARS-COV-2 main protease (in vivo)

A small molecule inhibitor shows promise to reduce the growth of uveal melanoma

A small molecule inhibitor shows promise to reduce the growth of uveal melanoma

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

Yale School of Public Health and Tevogen Bio partner to expand school's regulatory sciences program

Neutralizing aptamers block SARS-CoV-2 infection in vitro

Neutralizing aptamers block SARS-CoV-2 infection in vitro

Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities

Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities

Static magnetic field from MRI scanner decreases blood-brain barrier opening volume

Static magnetic field from MRI scanner decreases blood-brain barrier opening volume

New approach that uses machine learning could transform drug development

New approach that uses machine learning could transform drug development

Study opens up new opportunities for controlling tuberculosis

Study opens up new opportunities for controlling tuberculosis

Pfizer aims to implement boosters and a new vaccine based on SARS-CoV-2 Delta variant

Pfizer aims to implement boosters and a new vaccine based on SARS-CoV-2 Delta variant

Durable antibody response at least 8 months following vaccination with J&J COVID vaccine

Durable antibody response at least 8 months following vaccination with J&J COVID vaccine